Company Overview of SARcode Bioscience Inc.
SARcode Bioscience Inc. develops small molecule compounds for the treatment of ophthalmic and dermatologic inflammations caused due to T-cells. It involves in the development of a lymphocyte function-associated antigen-antagonists for the treatment of T-cell mediated inflammatory diseases. The company was founded in 2006 and is based in Brisbane, California. As of April 17, 2013, SARcode Bioscience Inc. operates as a subsidiary of Shire plc.
1000 Marina Boulevard
Brisbane, CA 94005
Founded in 2006
Key Executives for SARcode Bioscience Inc.
SARcode Bioscience Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Innovative BioTherapies, Inc.||United States|
|Signal Pharmaceuticals, LLC||United States|
|Opsonix, Inc.||United States|
|EpiBiome, Inc.||United States|
|ProstaGene, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact SARcode Bioscience Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.